4 results match your criteria: "University of Mohamed V Rabat[Affiliation]"
BMC Cancer
October 2020
National Institute Of Oncology, Department of Medical Oncology, Mohamed V University in Rabat, Rabat, Morocco.
Background: Moroccan incidence of cancer is increasing with the lengthening of life expectancy. Data regarding elderly Moroccan cancer patients are lacking. In the context of our project aiming to develop an adapted version of the Comprehensive Geriatric Assessment CGA to the Moroccan population, we launched the first Moroccan multicenter transverse study to explore the characteristics of elderly Moroccan cancer patients.
View Article and Find Full Text PDFPan Afr Med J
June 2017
Department of Pharmacology and Toxicology, Faculty of Medicine and Pharmacy, University of Mohamed V Rabat 10170, Morocco.
The objective of this work is to demonstrate the interest of integration of pharmacovigilance in Moroccan Tuberculosis Control Program (MTCP). The integration of pharmacovigilance in MTCP was conducted in October 2012with the Global Fund support. We compared the reports notified before and after this integration (period 1: January 2010-October2012; period 2: October 2012-December 2013).
View Article and Find Full Text PDFAnn Pharm Fr
May 2017
Service of pharmacy, National institute of oncology, 10170 Rabat, Morocco.
A 48-year-old woman developed palmoplantar hyperkeratosis during treatment with imatinib (400mg/day) for treatment of chronic myeloid leukemia. After 5months of treatment, she developed plantar lesions with yellow-brownish plaques and palmar desquamations. The skin biopsy has eliminated psoriasis.
View Article and Find Full Text PDFPLoS One
May 2017
Equipe de recherche ONCOGYMA, University of Mohamed V Rabat, Faculty of Medicine and Pharmacy of Rabat, Avenue Mohammed Belarbi El Alaoui-Souissi-BP 6203 Rabat, Morocco.
Background: Breast cancer in young women is quite uncommon and shows more aggressive characteristics with major disparities between worldwide populations. Prognosis and outcome of breast cancer in young patients are widely studied, but still no consensus is available.
Methods: We retrospectively included 716 cases of breast cancer women diagnosed in 2009 at the National Institute of Oncology of Rabat.